Stocks · News reference

Apollomics Announces $10M Private Placement Of Up To 700,001 Class A Ordinary Shares At $15 Per Share, Including $2M Note Conversion By CEO Howard Chen

Aug 11, 2026, 8:39 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 11, 2026, 9:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings report
ABSI APLM ARAY CCM CRDF
BenzingaJul 13, 2026, 2:13 PMBenzinga Newsdesk
Apollomics shares are trading higher after the company announced it has regained Nasdaq compliance.
APLM
BenzingaJul 13, 2026, 12:01 PMBenzinga Newsdesk
Apollomics Regains Nasdaq Compliance
Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and
APLM